Kathleen M Phelan - JoVE Visualize

Showing results (1-10 of 5) with videos related to

Pageof 1

Sort By:

Organic Letters|November 25, 2003

Microwave-assisted synthesis utilizing supported reagents: a rapid and efficient acylation procedureDaryl R Sauer, Douglas Kalvin, Kathleen M Phelan

The Journal of Clinical Psychiatry|December 9, 2003

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugsKathleen M Phelan, Andrew D Mosholder, Susan Lu

Bioorganic & Medicinal Chemistry Letters|October 12, 2005

Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitorsIrini Akritopoulou-Zanze, Daria Darczak, Kathy Sarris, et al.

Bioorganic & Medicinal Chemistry Letters|June 19, 2004

Synthesis and antibacterial activity of novel bifunctional macrolidesIrini Akritopoulou-Zanze, Kathleen M Phelan, Thomas G Marron, et al.

Bioorganic & Medicinal Chemistry Letters|June 6, 2006

Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitorsJürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.

Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:

Pageof 1

Organic Letters|November 25, 2003

Microwave-assisted synthesis utilizing supported reagents: a rapid and efficient acylation procedureDaryl R Sauer, Douglas Kalvin, Kathleen M Phelan

The Journal of Clinical Psychiatry|December 9, 2003

Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugsKathleen M Phelan, Andrew D Mosholder, Susan Lu

Bioorganic & Medicinal Chemistry Letters|October 12, 2005

Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitorsIrini Akritopoulou-Zanze, Daria Darczak, Kathy Sarris, et al.

Bioorganic & Medicinal Chemistry Letters|June 19, 2004

Synthesis and antibacterial activity of novel bifunctional macrolidesIrini Akritopoulou-Zanze, Kathleen M Phelan, Thomas G Marron, et al.

Bioorganic & Medicinal Chemistry Letters|June 6, 2006

Hit-to-lead optimization of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of KDR kinase inhibitorsJürgen Dinges, Irini Akritopoulou-Zanze, Lee D Arnold, et al.

Pageof 1